Xeltis Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $11.7M
Latest Deal Amount
  • Investors
  • 7

Xeltis General Information

Description

Producer of a clinical-stage medical device company intended to provide a restorative approach to cardiovascular therapy. The company's device comprises the bioabsorbable heart valves and blood vessels designed to allow Endogenous Tissue Restoration (ETR) which is the natural restoration of the complex body part they replace upon implantation, enabling the patients body to naturally restore a new blood vessel or heart valve through a therapeutic approach called Endogenous Tissue Restoration (ETR).

Contact Information

Website
www.xeltis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • Seefeldstrasse 69
  • 8008 Zurich
  • Switzerland

Xeltis Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xeltis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series D) 05-Sep-2019 $11.7M 00000 000.00 Completed Clinical Trials - General
8. Later Stage VC (Series C) 15-Nov-2017 000.00 00000 Completed Clinical Trials - General
7. Later Stage VC (Series B) 27-Nov-2015 000.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 08-Dec-2014 000.00 000.00 00000 Completed Clinical Trials - General
5. Later Stage VC (Series A) 15-Oct-2013 00.00 000.00 000.00 Completed Startup
4. Later Stage VC 08-May-2012 00.000 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 04-May-2011 00.000 00.000 000.00 Completed Generating Revenue
2. Early Stage VC 16-Nov-2009 $3.01M $4.22M 00.000 Completed Startup
1. Early Stage VC 11-Jul-2008 $1.21M $1.21M 00.000 Completed Startup
To view Xeltis’s complete valuation and funding history, request access »

Xeltis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Preferred C1 shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
Preferred B shares 000,000 00.000000 000.00 000.00 00 000.00 0.000
Preferred B shares 000,000 00.000000 000.00 000.00 00 000.00 00.00
Preferred B shares 000,000 00.000000 000.0 000.0 00 000.0 0.000
Preferred A Shares 000,000 00.000000 000.0 000.0 00 000.0 0.00
Ordinary shares 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary shares 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary shares 137,600 $1.110627 $24.68 $24.68 1x $24.68 2.68%
Ordinary shares 30,000 $1.110627 $18.51 $18.51 1x $18.51 0.58%
To view Xeltis’s complete cap table history, request access »

Xeltis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Producer of a clinical-stage medical device company intended to provide a restorative approach to cardiovascular therapy
Therapeutic Devices
Zurich, Switzerland
34 As of 2021
00000
00.00 0000-00-00
00000000000 00000

000000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
00000000000 0000000
Eagan, MN
0000
000000000 - 0000

00 00000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
00000000000 0000000
Singapore, Singapore
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xeltis Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardia Angel-Backed Eagan, MN 0000 000000000 - 0000
00 00000000 Corporate Backed or Acquired Singapore, Singapore 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
0000000 Venture Capital-Backed Clichy, France 00 000.00 00000000000 000.00
000000000 0000000 Formerly VC-backed Exton, PA 00 000.00 000000&0 000.00
You’re viewing 5 of 17 competitors. Get the full list »

Xeltis Executive Team (31)

Name Title Board Seat Contact Info
Eliane Schutte Chief Executive Officer, Board Member & Chief Development Officer
Martijn Cox Ph.D Chief Technology Officer & Co-Founder
Mark La Meir Ph.D Independent Clinal Advisor
Christian Spaulding MD Medical Advisory Board Member
Francesco Maisano MD Medical Advisory Board Member
You’re viewing 5 of 31 executive team members. Get the full list »

Xeltis Board Members (13)

Name Representing Role Since
Christian Wenger Ph.D Self Board Member 000 0000
Clemens Van Blitterswijk Ph.D Life Sciences Partners Board Member 000 0000
Diego Braguglia Ph.D VI Partners Board Member 000 0000
Eliane Schutte Xeltis Chief Executive Officer, Board Member & Chief Development Officer 000 0000
George Fazio Xeltis Chairman 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Xeltis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xeltis Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ysios Capital Venture Capital Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
Life Sciences Partners Venture Capital Minority 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »